Should psoriasis patients continue biologics during the COVID-19 pandemic? Plus CMS implements changes to aid the COVID-19 response
Dr. Lawrence Green discusses how to counsel patients who are taking biologics to control their psoriasis during the COVID-19 pandemic. Plus, CMS implements temporary regulatory changes to aid COVID-19 response.
Thursday, April 2, 2020